What happens when you take apixaban with fish oil?
Apixaban (brand name Eliquis) is a direct oral anticoagulant, and fish oil supplies the omega-3 fatty acids EPA and DHA, which have a mild blood-thinning effect of their own. When the two are combined, their effects on clotting add together. Here is the sequence:
- Apixaban blocks factor Xa. Factor Xa is an enzyme near the end of the coagulation cascade, the point where the cascade converges to produce thrombin. By inhibiting it, apixaban reduces clot formation, which is why it is used in atrial fibrillation, in treating and preventing venous blood clots, and after some orthopaedic surgery.
- Fish oil omega-3s enter platelet membranes. EPA and DHA become incorporated into the membranes of platelets, the cells that start clots by clumping together.
- Platelet chemistry shifts. Once incorporated, the omega-3s change the balance of prostaglandins and thromboxanes platelets make, mildly reducing their tendency to clump. This is a real but generally modest antiplatelet effect, and it works by a different route than apixaban.
- The two effects stack. Apixaban slows one part of clotting and omega-3s slow another, so in theory the combined result is slightly more bleeding tendency than apixaban alone.
Importantly, large pooled trial data are reassuring at ordinary supplement levels: omega-3 intake at typical doses was not linked to a meaningful rise in bleeding. The signal that does appear is small and confined to very high, prescription-strength omega-3 use.
Why is this important?
This combination deserves attention mainly because the strength of fish oil products varies enormously, not because everyday fish oil routinely causes bleeding with apixaban.
A modest drugstore softgel contains only a small amount of EPA and DHA, while high-potency supplements and prescription-strength omega-3 products deliver far more per dose. The small bleeding signal in the research sat at the very high end of that spectrum, not in the typical supplement range.
Apixaban already raises bleeding risk on its own; that is the trade-off for preventing strokes and clots. Adding a high-dose omega-3 product layers a measurable, though small, extra risk on top. For older adults, people with reduced kidney function, and anyone also taking aspirin or another antiplatelet for heart disease, even a small additional bleeding risk can matter clinically.
There is also no convenient lab check. Apixaban, unlike warfarin, has no routine monitoring blood test, and the antiplatelet effect of omega-3s does not show up on standard labs either. The first sign of a problem is usually clinical: a bruise that keeps growing, a nosebleed that will not stop, or blood in the stool or urine.
What should you do?
The core principle is coordination with the clinician who manages your apixaban, plus attention to bleeding signs. Use this schedule:
Before any change (starting, stopping, or adjusting fish oil):
- Tell the clinician who manages your apixaban about every supplement you take, including fish oil, krill oil, algal oil, and cod liver oil.
- Do not start a high-dose, prescription-strength omega-3 product on your own. If one has been recommended for high triglycerides or heart-disease risk, treat it as a coordination question for your prescriber, not a self-management decision.
- Ask your doctor or pharmacist what dose, if any, is appropriate for you rather than guessing from the label.
Every day while taking both:
- Take fish oil as agreed with your clinician and stick to that plan rather than escalating the dose on your own.
- Watch for bleeding signs and act on them: a nosebleed lasting more than about ten minutes, bleeding gums when brushing, pink or red urine, black or tarry stools, coffee-ground vomiting, large new bruises, prolonged bleeding from small cuts, unusually heavy menstrual bleeding, severe headache, new weakness or numbness, or a change in vision. Severe symptoms warrant an emergency room visit.
- When reading a label, look at the total EPA plus DHA per serving, not just the total fish oil per softgel.
After a change, or before a procedure:
- Before elective surgery or dental work, tell the team about your fish oil use along with your apixaban. Many clinicians ask patients to pause fish oil a few days beforehand as part of the perioperative plan, in tandem with any apixaban hold.
- If you stop or restart fish oil, let your prescriber know so your overall bleeding risk can be reassessed.
Which specific products are affected?
This applies to oral omega-3 products of all kinds: standard fish oil softgels, krill oil, algal oil, cod liver oil, high-concentration triglyceride or ethyl-ester fish oil, and prescription omega-3 products such as icosapent ethyl (Vascepa) and omega-3 acid ethyl esters (Lovaza, Omtryg). The number that matters on the label is the combined EPA plus DHA per serving, since that is what drives the antiplatelet effect, rather than the total fish oil per softgel.
On the medication side, the interaction concerns apixaban (Eliquis) as the anticoagulant. The same general caution applies to other direct oral anticoagulants and to anyone combining omega-3s with antiplatelet drugs such as aspirin.
Eating fatty fish such as salmon, mackerel, sardines, or trout a few times a week as part of a normal diet has not been associated with bleeding on apixaban and is generally encouraged for heart health. The bleeding signal is tied to concentrated supplement doses, particularly at the very high end, not to fish in the diet.
The science behind it
The most relevant evidence is a 2024 systematic review and meta-analysis by Javaid and colleagues, published in the Journal of the American Heart Association, which pooled fifteen randomised trials covering more than 120,000 patients. Its headline finding was reassuring: omega-3 polyunsaturated fatty acids were not associated with a significant increase in total bleeding or central-nervous-system bleeding compared with control. A small absolute increase in bleeding events appeared only at the very high, purified-EPA prescription doses used in cardiovascular trials, and bleeding risk tracked more closely with the omega-3 dose than with whether patients were also on antiplatelet therapy.
This is why the practical message is measured rather than alarmist: at ordinary supplement levels the data do not show a meaningful bleeding increase, and the concern is concentrated at prescription-strength doses. Tertiary drug-interaction references, such as Drugs.com, likewise classify apixaban with fish oil as a moderate interaction, consistent with a real but generally manageable additive effect.
References: Javaid A, et al. Bleeding Risk in Patients Receiving Omega-3 PUFAs: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2024 (https://pmc.ncbi.nlm.nih.gov/articles/PMC11179820/). Drugs.com drug interactions: apixaban with fish oil, moderate (https://www.drugs.com/drug-interactions/apixaban-with-fish-oil-3438-0-1749-3873.html).
Frequently Asked Questions
Can I take fish oil at all while on apixaban?
For most people, standard fish oil supplements are considered low-risk on apixaban, and many clinicians allow them as long as they know you are taking one. The key is to tell the clinician who manages your apixaban and agree on an appropriate amount rather than deciding on your own.
Is high-dose prescription omega-3 different from a normal supplement?
Yes. The small bleeding signal in the research was tied to very high, prescription-strength omega-3 use, not to typical supplements. Do not start a prescription-strength omega-3 product without explicit guidance from the clinician managing your apixaban.
Will my routine blood tests catch a problem?
No. Apixaban has no routine monitoring test the way warfarin does, and the antiplatelet effect of omega-3s does not show up on standard labs. The earliest warning is usually a physical sign, such as a growing bruise or a nosebleed that will not stop.
What bleeding signs should make me call my doctor?
Contact your prescriber for a nosebleed lasting more than about ten minutes, bleeding gums, pink or red urine, black or tarry stools, coffee-ground vomiting, or large new bruises. A severe headache, new weakness or numbness, or vision changes warrant an emergency room visit.
Do I need to stop fish oil before surgery or dental work?
Often, yes. Many clinicians ask patients to pause fish oil a few days before a procedure, alongside any apixaban hold. Tell the surgical or dental team about both, and follow their specific instructions.
Is eating fish a problem on apixaban?
No. Eating fatty fish such as salmon, sardines, or mackerel a few times a week has not been associated with bleeding on apixaban and is generally encouraged for heart health. The concern is with concentrated high-dose supplements, not fish in the diet.
Key takeaways
- Fish oil omega-3s have a mild antiplatelet effect that can theoretically add to apixaban's bleeding risk, but pooled trial data show no significant increase at typical supplement levels.
- The small bleeding signal in the research was confined to very high, prescription-strength omega-3 doses, which is why this is a moderate, manageable interaction rather than a severe one.
- Tell the clinician who manages your apixaban about any fish oil, and do not start a prescription-strength omega-3 product without their approval.
- Apixaban has no routine monitoring test, so watch for bleeding signs and report them promptly.
- Before surgery or dental work, disclose both apixaban and fish oil, and follow the team's instructions on pausing them.
- Eating fatty fish as part of a normal diet is not a concern and remains encouraged for heart health.